Search Results - "Braunstein, Inbal"

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms by Parry, Richard V., Chemnitz, Jens M., Frauwirth, Kenneth A., Lanfranco, Anthony R., Braunstein, Inbal, Kobayashi, Sumire V., Linsley, Peter S., Thompson, Craig B., Riley, James L.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare by Braunstein, Inbal, MD, Goodman, Noah G., MPH, Rosenbach, Misha, MD, Okawa, Joyce, RN, Shah, Asha, MD, Krathen, Michael, MD, Kovarik, Carrie L., MD, Luning Prak, Eline, MD, PhD, Werth, Victoria P., MD

“…Background Lenalidomide is a thalidomide analogue that may serve as an adjunctive therapy for treatment-refractory cutaneous lupus erythematosus (CLE)…”
Get full text

Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy by Braunstein, Inbal, Werth, Victoria

“…Autoimmune skin disease occurs in pregnancy, and treatment is often required to control both maternal disease and fetal outcomes. Here we present the available…”
Get full text

Childhood ALL and second neoplasms by Maniar, Tapan N., Braunstein, Inbal, Keefe, Stephen, Hussen, Sofia, Abrams, Tara, De Michele, Angela, El-Deiry, Wafik S.

“…Second malignancies are a significant concern for survivors of childhood acute lymphoblastic leukemia (ALL), in particular patients who have been treated with…”
Get full text

Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy: Treatment of autoimmune skin diseases in pregnancy by Braunstein, Inbal, Werth, Victoria

Get full text

Mucinous nevus: report of a case and review of the literature by Cobos, Gabriela, Braunstein, Inbal, Abuabara, Katrina, Chu, Emily Y, James, William

Get more information

Antibiotic Sensitivity and Resistance Patterns in Pediatric Staphylococcal Scalded Skin Syndrome by Braunstein, Inbal, Wanat, Karolyn A., Abuabara, Katrina, McGowan, Karin L., Yan, Albert C., Treat, James R.

“…Historical resistance patterns often guide empiric antibiotic choices in staphylococcal scalded skin syndrome (SSSS), but little is known about the difference…”
Get full text

Update on management of connective tissue panniculitides by Braunstein, Inbal, Werth, Victoria P.

“…In connective tissue diseases, panniculitis can be the sole manifestation or can occur along with the underlying disease process. The best described forms of…”
Get full text

Update on management of connective tissue panniculitides: Panniculitis by Braunstein, Inbal, Werth, Victoria P.

Get full text

Vemurafenib‐induced interface dermatitis manifesting as radiation‐recall and a keratosis pilaris‐like eruption by Braunstein, Inbal, Gangadhar, Tara C., Elenitsas, Rosalie, Chu, Emily Y.

“…Vemurafenib is a specific inhibitor of the V600E mutated BRAF protein kinase used for the treatment of unresectable or metastatic melanoma harboring this…”
Get full text

Eltrombopag-associated hyperpigmentation by Braunstein, Inbal, Wanat, Karolyn A, Elenitsas, Rosalie, Xu, Xiaowei, Frey, Noelle, Rosenbach, Misha

Get more information

B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs by Chemnitz, Jens M, Lanfranco, Anthony R, Braunstein, Inbal, Riley, James L

“…The B and T lymphocyte attenuator (BTLA) is a recently identified member of the CD28 family of cell receptors. Initial reports demonstrated that mice deficient…”
Get full text

Bier spots: a benign vascular anomaly by He, Alice, Kwatra, Shawn G, Kim, Noori, Braunstein, Inbal

“…Bier spots are completely asymptomatic and are often found on the extensor surfaces of the upper and lower extremities, although they are sometimes…”
Get full text

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms by Chemnitz, Jens M., Riley, James L., Frauwirth, Kenneth A., Braunstein, Inbal, Kobayashi, Sumire V., Linsley, Peter S., Thompson, Craig B., Parry, Richard V.

“…CTLA-4 and PD-1 are receptors that negatively regulate T cell activation. Ligation of both CTLA-4 and PD-1 blocked CD3/CD28 mediated upregulation of glucose…”
Get full text

Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption by Braunstein, Inbal, Gangadhar, Tara C., Elenitsas, Rosalie, Chu, Emily Y.

Get full text